EUVIMEDEUVIMED entdecken
Crossref

Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer

Nobumitsu Ikeuchi, Fumiyasu Igata, Eriko Kinoshita, Toshiaki Kawabata, Ibun Tan, Yusuke Osaki, Rikako Otsuka, Rintaro On, Takato Ikeda, Akira Nakao, Tomoya Sasaki, Takashi Aoyama und 5 weitere

Anticancer Research · 2023

DOI: 10.21873/anticanres.16210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Nobumitsu Ikeuchi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansMaleAgedFemaleCarboplatinPaclitaxelBevacizumabB7-H1 AntigenEast Asian PeopleRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

ABCP therapyIMpower150 studyNSCLCatezolizumabprogrammed death ligand 1

Substanzen

CarboplatinPaclitaxelBevacizumabB7-H1 AntigenatezolizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan.
  • Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan hinoue@fukuoka-u.ac.jp.

Zitieren

APA

Ikeuchi, N., Igata, F., Kinoshita, E., Kawabata, T., Tan, I., Osaki, Y., Otsuka, R., On, R., Ikeda, T., Nakao, A., Sasaki, T., Aoyama, T., Hirano, R., Harada, T., Ebi, N., Fujita, M., & Inoue, H. (2023). Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.16210

Vancouver

Ikeuchi N, Igata F, Kinoshita E, Kawabata T, Tan I, Osaki Y, et al. Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer. Anticancer Research. 2023. doi:10.21873/anticanres.16210

BibTeX
@article{Ikeuchi2023,
  author = {Ikeuchi, Nobumitsu and Igata, Fumiyasu and Kinoshita, Eriko and Kawabata, Toshiaki and Tan, Ibun and Osaki, Yusuke and Otsuka, Rikako and On, Rintaro and Ikeda, Takato and Nakao, Akira and Sasaki, Tomoya and Aoyama, Takashi and Hirano, Ryosuke and Harada, Taishi and Ebi, Noriyuki and Fujita, Masaki and Inoue, Hiroyuki},
  title = {Real-world Efficacy and Safety of Atezolizumab Plus Bevacizumab, Paclitaxel and Carboplatin for First-line Treatment of Japanese Patients With Metastatic Non-squamous Non-small Cell Lung Cancer},
  journal = {Anticancer Research},
  year = {2023},
  doi = {10.21873/anticanres.16210}
}
Kostenlos starten →